| GRP78 and CHOP modulate macrophage apoptosis and the development of bleomycin‐induced pulmonary fibrosis EA Ayaub, PS Kolb, Z Mohammed‐Ali, V Tat, J Murphy, PS Bellaye, ... The Journal of pathology 239 (4), 411-425, 2016 | 118 | 2016 |
| Endoplasmic reticulum stress inhibition reduces hypertension through the preservation of resistance blood vessel structure and function RE Carlisle, KE Werner, V Yum, C Lu, V Tat, M Memon, Y No, K Ask, ... Journal of hypertension 34 (8), 1556-1569, 2016 | 47 | 2016 |
| Protein misfolding and endoplasmic reticulum stress in chronic lung disease: will cell-specific targeting be the key to the cure? S Naiel, V Tat, M Padwal, M Vierhout, O Mekhael, T Yousof, A Ayoub, ... Chest 157 (5), 1207-1220, 2020 | 27 | 2020 |
| Endoplasmic reticulum stress inhibition blunts the development of essential hypertension in the spontaneously hypertensive rat S Naiel, RE Carlisle, C Lu, V Tat, JG Dickhout American Journal of Physiology-Heart and Circulatory Physiology 316 (5 …, 2019 | 25 | 2019 |
| FK506-binding protein 13 expression is upregulated in interstitial lung disease and correlated with clinical severity. A potentially protective role V Tat, EA Ayaub, A Ayoub, M Vierhout, S Naiel, MK Padwal, S Abed, ... American Journal of Respiratory Cell and Molecular Biology 64 (2), 235-246, 2021 | 12 | 2021 |
| TDAG51 induces renal interstitial fibrosis through modulation of TGF-β receptor 1 in chronic kidney disease RE Carlisle, Z Mohammed-Ali, C Lu, T Yousof, V Tat, S Nademi, ... Cell Death & Disease 12 (10), 921, 2021 | 11 | 2021 |
| Cell-specific drug targeting in the lung S Abed, R Turner, N Serniuck, V Tat, S Naiel, A Hayat, O Mekhael, ... Biochemical Pharmacology 190, 114577, 2021 | 11 | 2021 |
| Inhaled pirfenidone improves animal efficacy through superior pulmonary and vascular pharmacokinetics MW Surber, D Poulin, K McInally, J Chapdelaine, D Gendron, V Tat, ... A61. LUNG FIBROSIS: ANIMAL MODELS II, A6599-A6599, 2014 | 5 | 2014 |
| Mechanisms linked to differences in the mutagenic potential of 1, 3-dinitropyrene and 1, 8-dinitropyrene JA Holme, HE Nyvold, V Tat, VM Arlt, A Bhargava, KB Gutzkow, ... Toxicology Reports 1, 459-473, 2014 | 5 | 2014 |
| Endoplasmic reticulum stress causes renal epithelial cell disjunction JG Dickhout, J Chahal, A Matthews, RE Carlisle, V Tat, S Naiel J Pharma Reports 1 (107), 2, 2016 | 3 | 2016 |
| The Role of the IRE1α Pathway in Vascular Stiffening and Fibrosis V Tat | | 2017 |
| Effect Of Allergen Challenge On Inflammation Induced By Toll-Like Receptor Stimulation In A Nasal Challenge Model V Tat, JG Dickhout, K Ask, H Neighbour C101. ALLERGIC AIRWAY INFLAMMATION AND HYPERRESPONSIVENESS: NOVEL MECHANISMS …, 2015 | | 2015 |
| C101 ALLERGIC AIRWAY INFLAMMATION AND HYPERRESPONSIVENESS: NOVEL MECHANISMS AND THERAPY: Effect Of Allergen Challenge On Inflammation Induced By Toll-Like Receptor Stimulation … V Tat, JG Dickhout, K Ask, H Neighbour American Journal of Respiratory and Critical Care Medicine 191, 1, 2015 | | 2015 |
| Grp78 Heterozygosity Abrogates Bleomycin-Induced Lung Fibrosis By Modulating Er-Resident Protein Folding Capacity E Ayaub, V Tat, A Bhargava, E Lynn, C Shimbori, MRJ Kolb, R Austin, ... D96. WHY SO STRESSED? ENDOPLASMIC RETICULUM, PROTEIN FOLDING, AND OXIDATION …, 2014 | | 2014 |
| A61 LUNG FIBROSIS: ANIMAL MODELS II: Inhaled Pirfenidone Improves Animal Efficacy Through Superior Pulmonary And Vascular Pharmacokinetics MW Surber, D Poulin, K McInally, J Chapdelaine, D Gendron, V Tat, ... American Journal of Respiratory and Critical Care Medicine 189, 1, 2014 | | 2014 |
| D96 WHY SO STRESSED? ENDOPLASMIC RETICULUM, PROTEIN FOLDING, AND OXIDATION IN LUNG DISEASE: Grp78 Heterozygosity Abrogates Bleomycin-Induced Lung Fibrosis By Modulating Er … E Ayaub, V Tat, A Bhargava, E Lynn, C Shimbori, MRJ Kolb, R Austin, ... American Journal of Respiratory and Critical Care Medicine 189, 1, 2014 | | 2014 |
| Endoplasmic Reticulum Stress Causes Renal Epithelial Cell Disjunction D JG, J Chahal, A Matthews, RE Carlisle, V Tat | | |
| Inhalation improves pirfenidone animal efficacy through superior pulmonary and vascular pharmacokinetics MW Surber, D Poulin, K McInally, J Chapdelaine, D Gendron, V Tat, ... | | |
